AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05750264 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ibuprofen
Description: 800 mg of IV ibuprofen
Study NCT06435351 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Leukapheresis
Description: Removal of white blood cells (leukocytes) from the blood. The dendritic cells are harvested from the white blood cells that are collected and trained to recognize the specific abnormal proteins found in the tumor sample.~One needle is inserted in each arm. An apheresis machine removes blood from the vein in one arm, separates and retains the leukocytes from the blood, and then returns the rest of the blood to the other arm.
Study NCT06435351 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Dendritic Cell (DC) Vaccine
Description: The vaccine will be given intranodally (inguinal or axillary) under ultrasound guidance using a dose of 40-50 million cells three times spaced 2 weeks apart for the initial priming sequence.~3 doses of the priming vaccines are given once every 2 weeks. 2 booster shots (if available) will be given 6 months and 12 months following completion of initial priming vaccines.
Study NCT04809987 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Gait
Description: The subject will be stand up with a standing opposite a mirror (from the waist up) and a screen (from the waist down) where a video of treadmill gait of a person will be projected.
Study NCT04809987 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Physical Exercise
Description: Specific gait exercise was conducted.
Study NCT04809987 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical Exercise
Description: Specific gait exercise was conducted.
Study NCT04809987 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Documental projection
Description: The subject will be stand up with a standing opposite a mirror (from the waist up) and a screen (from the waist down) where video without any type of animal or human movement was showed.
Study NCT05520255 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18F-PSMA-1007
Description: 18F-PSMA-1007 intravenous injection
Study NCT06210724 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Faecal immunochemical test for haemoglobin, faecal calprotectin, faecal microbiome
Description: Faecal samples to be collected by patients at home and delivered via post to a bowel cancer screening hub for analysis
Study NCT05880134 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: conventional posterior nerve neurectomy
Description: A vertical incision is made behind the posterior fontanelle. The posterior end of the posterior fontanelle is identified by palpation with an elevator. .~The mucoperiosteum is raised gently using a Cottle elevator or a suction freer elevator, after making the initial incision. Care must be taken not to injure the sphenopalatine vessel during flap elevation.~The peripheral part of the posterior nasal nerve can usually be identified just behind the incision, about 4-5 mm inferior to the sphenopalatine artery or crista ethmoidalis.~I After identifying the nerve fibres, it is cauterised using monopolar suction cautery and cut using microscissors. It is essential to carry out this procedure on both sides for effective results.
Study NCT05880134 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: cartilage graft reinforcement after posterior nerve neurectomy
Description: A vertical incision is made behind the posterior fontanelle. The posterior end of the posterior fontanelle is identified by palpation with an elevator. .~The mucoperiosteum is raised gently using a Cottle elevator or a suction freer elevator, after making the initial incision. Care must be taken not to injure the sphenopalatine vessel during flap elevation.~The peripheral part of the posterior nasal nerve can usually be identified just behind the incision, about 4-5 mm inferior to the sphenopalatine artery or crista ethmoidalis.~I After identifying the nerve fibres, it is cauterised using monopolar suction cautery and cut using microscissors. It is essential to carry out this procedure on both sides for effective results.~then harvest cartilage from nasal septum and refashion it around sphenopalatine bundle to prevent nerve re-innervation~The mucoperiosteal flaps are repositioned . No nasal packing is required. Patients are discharged on the same day
Study NCT06276556 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ABP-671
Description: Participants who were randomized to any of the ABP-671 treatment groups in Part 1 or Part 2 of Study ABP-671-301 will continue to receive the same dose level and dosing regimen during the Treatment Period of this Extension Study.~Participants who were randomized to receive placebo in Part 1 or Part 2 of Study ABP-671-301 will receive ABP-671 during the Treatment Period of the Extension Study.
Study NCT06276556 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Allopurinol
Description: Participants who were randomized to receive allopurinol in Part 1 of Study ABP-671-301 will continue to receive allopurinol during the Treatment Period of the Extension Study.
Study NCT06492733 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FastWire System - Peripheral
Description: The Investigator can use the FastWire System during the procedure to cross CTO Caps and/or to cross multiple lesions.
Study NCT05197426 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Azacitidine
Description: Specified dose on specified days
Study NCT05197426 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Specified dose of specified days
Study NCT06442046 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active Case Management
Description: A case manager will work with families post-discharge to ensure that youth are connected to an appropriate community support. Case managers will also work with families to identify any social needs and provide support in accessing services as needed.
Study NCT06442046 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Treatment as usual
Description: Subjects will receive a list of youth serving community service agencies and provided a recommendation to connect to them.
Study NCT06442046 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual
Description: Subjects will receive a list of youth serving community service agencies and provided a recommendation to connect to them.
Study NCT05406232 — intervention group
Intervention type: PROCEDURE
Intervention: Biopsy
Description: Undergo tumor punch biopsy
Study NCT05406232 — intervention group
Intervention type: PROCEDURE
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT05406232 — intervention group
Intervention type: RADIATION
Intervention: Radiation Therapy
Description: Undergo RT
Study NCT06655103 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational movie
Description: There are three groups in this research. The 1st group will be shown an educational movie about intrathecal chemotherapy treatment before intrathecal chemotherapy treatment, the 2nd group will be shown a cartoon movie before intrathecal chemotherapy treatment, and the 3rd group will not receive any intervention before intrathecal chemotherapy treatment. In all groups, measurements will be made in parallel; fear and pain scales as well as electrodermal activity, pulse, respiration and O2 saturation values 30 minutes before IT chemotherapy treatment, in the second measurement; In the second measurement, electrodermal activity, pulse, respiration and O2 saturation values along with fear and pain scales 15 minutes before IT chemotherapy, and in the third measurement, electrodermal activity, pulse, respiration and O2 saturation values along with fear and pain scales will be evaluated within 30-60 minutes after IT chemotherapy treatment (when the sedation effect is over).
Study NCT06654518 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Preoperative CBCT for Bone Density and Ridge Width Measurement
Description: Participants in this arm underwent preoperative Cone Beam Computed Tomography (CBCT) scanning to evaluate bone density and alveolar ridge width. The CBCT scans provide high-resolution, 3D images, which was used to guide the planning and placement of dental implants. The primary goal of the intervention was to assess how well the measurements obtained from CBCT could predict the primary stability of the implants postoperatively.
Study NCT06596421 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: abdominal massage
Description: abdominal massage
Study NCT06595641 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transfer Energy Capacitive Resistive Therapy
Description: It's a physical treatment modality commonly used to treat musculoskeletal pain. It normally uses a longwave radiofrequency of \~0.5 MHz. The system consists of a neutral plate and two different electrodes that can transfer energy in two modalities: capacitive and resistive
Study NCT06595641 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: strength training program
Description: Each session includes five exercises, each performed for three sets of 10 repetitions:~Shoulder Retraction - Strengthens muscles between shoulder blades. Shoulder Scaption - Improves stability and range of motion. Shoulder External Rotation from Side Lying - Targets rotator cuff muscles. Shoulder Protraction - Enhances shoulder blade function. Shoulder Extension - Strengthens posterior shoulder muscles
Study NCT06595641 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: strength training program
Description: Each session includes five exercises, each performed for three sets of 10 repetitions:~Shoulder Retraction - Strengthens muscles between shoulder blades. Shoulder Scaption - Improves stability and range of motion. Shoulder External Rotation from Side Lying - Targets rotator cuff muscles. Shoulder Protraction - Enhances shoulder blade function. Shoulder Extension - Strengthens posterior shoulder muscles
Study NCT06596850 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Wheelchair Skills Training Program
Description: Participants will receive 5, 45-minute weekly WC skills training sessions that will take place in the community, in and around the participants home. Each session will be customized to the participant's' goals and based on the learner's impairments (i.e., weakness, spasticity, movement disorders \[e.g. ataxia, tremor\], contractures, cognition). The WSTP sessions will begin with a 5-minute review of goals/progress, followed by a 10-minute warm-up (wheeling activities, random practice of previously leaned skills); 20 minutes of attempting new skills (training on each skill will be carried to next session until the skills are learned or until the trainer and participant mutually agree that training should be abandoned; the trainer will periodically ask the participant to practice newly learned skills to incorporate variability of practice); 10 minute cool-down, during which the participant will practice skills in a self-controlled environment.
Study NCT06590272 — intervention group
Intervention type: DEVICE
Intervention: TECNIS PCB00 intraocular lens
Description: In this study, we select TECNIS PCB00 IOL for inserting in the eyes during the cataract surgery
Study NCT06590272 — intervention group
Intervention type: DEVICE
Intervention: HumanOptics Diff-Aay intraocular lens
Description: In this study, we select HumanOptics Diff-Aay IOL for inserting in the eyes during the cataract surgery
Study NCT06590272 — intervention group
Intervention type: DEVICE
Intervention: TECNIS Symfony ZXR00 intraocular len
Description: In this study, we select TECNIS Symfony ZXR00 IOL for inserting in the eyes during the cataract surgery
Study NCT06590272 — intervention group
Intervention type: DEVICE
Intervention: ZEISS AT LISA tri 839MP intraocular len
Description: In this study, we select ZEISS AT LISA tri 839MP IOL for inserting in the eyes during the cataract surgery
Study NCT06592560 — intervention group
Intervention type: DEVICE
Intervention: ELISA
Description: Specific test: Assay of asprosin marker will be measured by enzyme-linked immunosorbent assay ( ELISA).
Study NCT06594276 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Local instillation of antibiotics
Description: Systemic antibiotics are usually used with needle aspiration of breast abscess. However local instillation of antibiotics will be an in intervention in this study.
Study NCT06596122 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D (Cholecalciferol )
Description: In conjunction with the AC-T chemotherapy protocol, individuals in the intervention group who have a vitamin D deficiency will receive an oral loading dose of 50,000 IU weekly for eight weeks. Subsequently, they will be given 100,000 IU monthly until the completion of their chemotherapy treatment.
Study NCT06585839 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital coaching solution to improve childbirth experience
Description: Intervention provides coaching to improve the childbirth experience and offers comprehensive perinatal mental health support to pregnant and postpartum women. It features emotion tracking and exercise customization functionality, along with an avatar-based platform. The app includes digital psychotherapy exercises and psychoeducation. These core elements are complemented by exercises in mindfulness, relaxation, and self-soothing.
Study NCT06585839 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Application for the control group
Description: Application for the control group including surveys.
Study NCT06601777 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Immediate application of the Smart Homespital system
Description: The Smart Homespital system can be applied for the first 3 months (12 weeks), and then the primary and secondary variables will be evaluated at 3, 6, 9months. While applying the Smart Homespital system, exercise three times a week, measure sleep twice a week, and questionnaire assessments (mMRC, CRQ, EQ-5D, K-CESD) are conducted once every two weeks.
Study NCT06601777 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Delayed application of the Smart Homespital system after 3 months
Description: The waiting list-control group will receive general medical services for the first 3 months and will receive a Smart Homespital system for 3-6 months. Primary and secondary variables will be monitored between 3, 6, and 9 months. While applying the Smart Homespital system, exercise three times a week, measure sleep twice a week, and questionnaire assessments (mMRC, CRQ, EQ-5D, K-CESD) are conducted once every two weeks.
Study NCT06593184 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Trans-spinal magnetic stimulation
Description: Trans-spinal magnetic stimulation activate affertent spinal roots and increase cortical excitability.
Study NCT06593184 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Comparator
Description: Masking for trans-spinal magnetic stimulation. The sound of stimulation persists even though no magnetic pulses are being delivered
Study NCT06591676 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dysfunctional Attitude Scale (DAS)
Description: Dysfunctional Attitude Scale (DAS) is a self-report scale designed to measure the presence and intensity of dysfunctional attitudes. It is widely used to assess impaired cognitive patterns associated with depression and other mental health conditions. Initially developed in English, its usefulness can be extended by translating and culturally adapting it into Urdu language.
Study NCT06595316 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise intervention group
Description: Exercise will consist of two supervised sessions per week. Starting with vital signs monitoring (blood pressure, temperature, blood oxygen levels, heart rate).~The aerobic component consists of a 5-minute warm-up, followed by 3 bouts of 4-minute cycling at an intensity of 60-65% HRR, with 2-minute active recovery periods in between and a 5-minute cool down. The goal is to increase up to an intensity of around 80%-85% HRR by weeks 16 to 18. Intensity will be monitored with The Borg Rating Scale of Perceived Exertion (RPE). The resistance component will consist of upper body and lower body exercises (door frame rows, wall push-ups, glute bridges, triceps lifts and squat to calf rise) starting on week one with a set of 12 repetitions of each exercise, with 2-minute recovery in between exercises aiming to increase the number of sets and reducing the number of repetitions.
Study NCT06586424 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Anion gap
Description: Patient was taken blood examination before PPCI
Study NCT06590506 — intervention group
Intervention type: DEVICE
Intervention: Wearable
Description: Continuous monitoring thought data recorded with wearable (Vivosmart Garmin bracelet)
Study NCT06603142 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Febuxostat 20MG Tablets
Description: Febuxostat 20MG Tablets
Study NCT06603142 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Febuxostat 20MG Placebo
Description: Febuxostat 20MG Placebo
Study NCT06603142 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AR882 25MG
Description: AR882 25 MG Capsules
Study NCT06603142 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AR882 12.5MG
Description: AR882 12.5 MG Capsules
Study NCT06603142 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: AR882 25MG Placebo
Description: AR882 25MG Placebo
Study NCT06603142 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: AR882 12.5MG Placebo
Description: AR882 12.5MG Placebo
Study NCT06603142 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Febuxostat 40MG Tablets
Description: Febuxostat 40MG Tablets
Study NCT06603142 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Febuxostat 40MG Placebo
Description: Febuxostat 40MG Placebo
Study NCT06598501 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS)
Description: an open arm study of 10 gambling disorder subjects will be conducted to determine the efficacy and feasibility of a multimodalistic therapy of rTMS and Cognitive Behavioral Therapy (CBT) for gambling disorder in Indonesia.
Study NCT06586801 — intervention group
Intervention type: OTHER
Intervention: Patient-reported outcome
Description: Patient-reported outcome data will be collected using the following instruments:EORTC QLQ-C30, EORTC QLQ-LC13, selected items from the PRO-CTCAE, EORTC-IL46.~The first collection of the information in questionnaires (EORTC QLQ-C30, EORTC QLQ-LC13, PRO-CTCAE \[select items\]), which defined as baseline- PROs, will be completed at Cycle 1, Day 1±7days prior to administration of study drug; then the rest times of collection will be completed at every two treatment cycle prior to administration of study drug (i.e., on Cycle 3, Day 1±7days; Cycle 5, Day 1±7days; Cycle 7, Day 1±7days; Cycle 9, Day 1±7days; Cycle 11, Day 1±7days; Cycle 13, Day 1±7days) . EORTC-IL46 will be completed at Cycle 3, Day 1±7days (baseline) prior to administration of study drug; then at every other study treatment cycle prior to administration of study drug (i.e., on Cycle 5, Day 1±7days; Cycle 7, Day 1±7days; Cycle 9, Day 1±7days; Cycle 11, Day 1±7days; Cycle 13, Day 1±7days)
Study NCT06590701 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Early dart throwing motion-mobilization
Description: We compare two different mobilisations in the rehabilitation of patients following scapholunate ligament reconstruction
Study NCT06590701 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Early dart throwing motion-mobilization
Description: We compare two different mobilisations in the rehabilitation of patients following scapholunate ligament reconstruction
Study NCT06603610 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Intensive geriatric service worker model of care
Description: Participants in the intervention group will receive care from an intensive geriatric service worker (IGSW), who will help the participant:~(i) Coordinate community resources and actively support participants' instrumental activities of daily living (IADLs) (e.g., linking participants with Meals-on-Wheels, taking participants to appointments) (ii) Advocate for support from home care for completing activities of daily living (ADLs) (iii) Implement patients' prioritized treatment recommendations made by healthcare professionals (e.g., supporting patients to purchase and install home safety equipment because this aligns with their values and preferences).
Study NCT06603610 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Information brochure and telephone follow-up support
Description: Participants will be e-mailed or mailed a booklet containing information about locally available resources including (1) meal preparation, (2) grocery delivery, (3) housekeeping, (4) pharmacies that deliver medications, (5) home care, and (6) Wheel-Trans. Participants will receive a scripted phone call from the study research coordinator one and three months after study enrolment to see if they have questions about the booklet material.
Study NCT06589609 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: FluBHPVE6E7
Description: Intratumoral administration for first dose followed by intramuscular administration for subsequent doses at recommended dose level and determined schedule.
Study NCT06604572 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Transabdominal preperitoneal approach
Description: The enrolled patients underwent either open tension-free hernia repair or Transabdominal preperitoneal approach
Study NCT06604572 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transabdominal preperitoneal approach
Description: The enrolled patients underwent either open tension-free hernia repair or Transabdominal preperitoneal approach
Study NCT06591624 — intervention group
Intervention type: OTHER
Intervention: Prolonged Mechanical Ventilation
Description: The neurosurgical patients who could extubated within 24 h after surgery
Study NCT06591624 — intervention group
Intervention type: OTHER
Intervention: remain intubation after surgery
Description: could not extubated after surgery and prolong mechanical ventilation for 48 hours